492 Results (Page 1 of 20)
US Markets Research Reports
US Lipid Disorder Therapeutics Market Analysis
The US Lipid Disorder Therapeutics Market was valued at $4,242 Mn in 2023 and is predicted to grow at a CAGR of 10.63% from 2023 to 2030, to $8,603.6 Mn by 2030. US Lipid Disorder Therapeutics Market is growing due to High Prevalence of Cardiovascular Diseases, Rising Geriatric Population and Advancements. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
US Head and Neck Cancer Therapeutics Market Analysis
The US Head and Neck Cancer Therapeutics Market was valued at $512.40 Mn in 2023 and is predicted to grow at a CAGR of 10.50% from 2023 to 2030, to $1030.73 Mn by 2030. The key drivers of this industry include the rising prevalence of Head and Neck cancer, improvement in diagnostic techniques, and growing awareness. The industry is primarily dominated by players such as Eli Lilly and Company, Merck, Bristol Myers Squibb, and AstraZeneca among others.
US Patient Adherence Programs Market Analysis
The US Patient Adherence Programs Market was valued at $5441.5 Mn in 2023 and is predicted to grow at a CAGR of 16% from 2023 to 2030, to $15378.9 Mn by 2030. The key drivers of the market include increasing non-adherence, healthcare cost containment, and increased demand for personalized healthcare. The prominent players in the US Patient Adherence Programs Market are Pfizer, Johnson & Johnson, Eli Lilly, Merck, and Amgen, among others.
US Medication Access Programs Market Analysis
The US Medication Access Programs Market was valued at $2305.6 Mn in 2023 and is predicted to grow at a CAGR of 12.6% from 2023 to 2030, to $5291.2 Mn by 2030. The key drivers of this industry include increasing chronic disease burden, rising healthcare costs, and pharmaceutical innovation. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
US Bariatric Surgery Devices Market Analysis
The US Bariatric Surgery Devices Marketwas valued at $1117.2 Mn in 2023 and is projected to grow at a CAGR of 3.2% from 2023 to 2023, to $1392.8 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Medtronic, Conmed Corporation, Johnson & Johnson among others.
US Hospital Market Analysis
The US Hospital Market was valued at $2,309.81 Bn in 2023 and is predicted to grow at a CAGR of 5.6% from 2023 to 2030, to $3,382.39 Bn by 2030. The key drivers of this industry are the rising prevalence of infectious diseases, technological advancements, and expansion of insurance coverage. The key players in the industry are Trinity Health, Cleveland Clinic, Massachusetts General Hospital, and Stanford Health Care among others.
US Contact Lenses Market Analysis
US Contact Lenses Market was valued at $7,198.80 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $11,484.29 Mn by 2030. The key drivers of this industry include the high prevalence of refractive errors, increasing demand for convenience, and technological advancements. The industry is primarily dominated by Bausch and Lomb, CooperVision, Alcon Vision, and Essilor among others.
US Oral Care Market Analysis
The US oral care market was valued at $14.8 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022 to 2030 and will reach $20.5 Bn in 2030. One of the main reasons propelling the growth of this market is increased awareness and an aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Koninklijke Philips N.V., Colgate-Palmolive Company, GlaxoSmithKline plc, Procter & Gamble, Johnson & Johnson, Unilever plc, Ultradent Products, Inc., 3M Company, Hain Celestial Group (Jason Natural Products, Inc.), Church & Dwight Co., Supersmile, and CloSYS among others.
US In Vitro Fertilization (IVF) Service Market Analysis
The US In Vitro Fertilization (IVF) Service Market was valued at $9429 Mn in 2023 and is predicted to grow at a CAGR of 5.42% from 2023 to 2030, to $13643.53 Mn by 2030. The key drivers of this industry include rising infertility rates, increasing disposable income, and technological advancements. The industry is primarily dominated by players such as CCRM Fertility, IVIRMA, ELITE IVF, and Boston IVF among others
US Bio-implant Market Analysis
The US Bio-implant Market was valued at $27300 Mn in 2023 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $35683.8 Mn by 2030. The US Bio-implant Market is growing due to Aging population, Rising prevalence of chronic diseases, Technological advancements. The market is primarily dominated by players such as Boston Scientific Corporation, Johnson & Johnson Services, Inc., Zimmer Biomet Holdings Inc, LifeNet Health, Smith & Nephew, Arthrex, Inc.
US Hemodialysis Equipment Market Analysis
The US Hemodialysis Equipment Market was valued at $5930.4 Mn in 2023 and is projected to grow at a CAGR of 5.6% from 2023 to 2023, to $8684.2 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Stryker, GE HealthCare, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.
US Dental Consumables Market Analysis
The US Dental Consumables Market was valued at $14196 Mn in 2023 and is projected to grow at a CAGR of 6.0% from 2023 to 2023, to $21345.5 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Anson Dental Supply, Align Technology, Zimmer Biomet, 3M, Carestream Dental among others.
US Primary Hyperoxaluria (PH) Therapeutics Market Analysis
US Primary Hyperoxaluria (PH) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. One of the key factors propelling the growth of the hyperoxaluria drug market is the rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Therapeutics Market are Allena Pharmaceuticals, Inc., Intellia Therapeutics, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
US Myelodysplastic Syndrome (MDS) Therapeutics Market Analysis
The US Myelodysplastic Syndrome (MDS) therapeutics market is projected to grow from $1.9 Bn in 2022 to $3.9 Bn by 2030, registering a CAGR of 9.3% during the forecast period of 2022-30. The market for pharmaceuticals for myelodysplastic syndrome (MDS) is growing as a result of a number of factors, including a rise in pediatric population, improved awareness, the launch of novel drugs, government initiatives to provide target-specific therapy, and favorable reimbursement policies. Major global players in this market are Abbott, Boehringer Ingelheim International GmbH, Johnson & Johnson Private Limited, MEI Pharma Inc., MTW Endoskopie Manufaktur, Aprea Therapeutics, Dr. Reddy's Laboratories Ltd, AbbVie Inc., Acceleron Pharma, Inc., Mylan N.V., Bristol-Myers Squibb Company, Eisai Co., Ltd., and LGM Pharma.
US Dental Caries Detectors Market Analysis
The US Dental Caries Detectors Market was valued at $95.8 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $152.9 Mn by 2030. US Dental Caries Detectors Market is growing due to the Prevalence of dental caries, Rising awareness, and Technological advancements. The industry is primarily dominated by players such as Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, Planmeca Oy, Adec Technologies, 3M ESPE, Morita Corporation, Woodpecker Medical Instruments Co., Softdent.
US Clinical Nutrition for Diabetes Care Market Analysis
The US Clinical Nutrition for Diabetes Care Market was valued at $903 Mn in 2023 and is predicted to grow at a CAGR of 2.78% from 2023 to 2030, to $1094.08 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Perrigo Company PLC, Eli Lilly, and Baxter International Inc. among others.
US Pharmacy Automation Device Market Analysis
The US Pharmacy Automation Device Market was valued at $2310 Mn in 2023 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to $3933.3 Mn by 2030. US Pharmacy Automation Device Market is growing due to Growing need to minimize medication errors, Rising Demand for Pharmaceuticals, and Increasing adoption among end-users. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC, Becton Dickinson and Company, Fulcrum Pharmacy Management, Inc.
US Clinical Nutrition Market Analysis
The US Clinical Nutrition Market was valued at $12,881.4 Mn in 2023 and is projected to grow at a CAGR of 3.34% from 2023 to 2023, to $16,212.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd, Mead Johnson & Company, LLC among others.
US Mental Health Apps Market Analysis
The US Mental Health Apps Market was valued at $2604 Mn in 2023 and is predicted to grow at a CAGR of 13.2% from 2023 to 2030, to $6202.49 Mn by 2030. The key drivers of this industry include rising mental illness, reduced stigma, and increasing smartphone penetration. The industry is primarily dominated by players such as HeadSpace, Calm, Happify, and Ksana Health among others.
US Cardiac Pacemakers Market Analysis
The US Cardiac Pacemakers Market was valued at $1699.7 Mn in 2023 and is predicted to grow at a CAGR of 1.20% from 2023 to 2030, to $1847.72 Mn by 2030. The key drivers of this industry include the increasing aging population, the rising incidence of chronic disease, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
US Clinical Nutrition for Cancer Care Market Analysis
The US Clinical Nutrition for Cancer Care Market was valued at $2,364.6 Mn in 2023 and is predicted to grow at a CAGR of 3.04 % from 2023 to 2030, to $2,916.07 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, increased awareness and education, and increasing healthcare expenditure. The prominent players of the US Clinical Nutrition for Cancer Care Market are Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, Pfizer, and Fresenius Kabi, among others.
US Gram-Negative Infection Therapeutics Market Analysis
The US Gram-Negative Infection Therapeutics Market was valued at $6247.5 Mn in 2023 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030 to $8166.1 Mn by 2030. A key factor driving this market growth is decreasing antibiotic resistance trends in gram-negative bacteria, increasing prevalence, and innovative therapeutics. Leading companies in this market include Pfizer Inc. and AbbVie Inc. (Allergan Pharmaceuticals Private Limited), among others.
US Home Infusion Therapy Market
The US Home Infusion Therapy Market was valued at $15103.2 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030, to $22860 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the US Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
US Hepatitis A Therapeutics Market Analysis
The US Hepatitis A Therapeutics Market was valued at $309.62 Mn in 2023 and is predicted to grow at a CAGR of 0.2% from 2023 to 2030 to $313.98 Mn by 2030. One of the key drivers of this industry includes disease prevalence and therapeutic demand, as evidenced by a 270% increase in reported cases to 12,474 in 2018, followed by a continued rise to 18,846 cases and above. The top players are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., etc.
US Frontotemporal Disorders Therapeutics Market Analysis
US Glioblastoma Multiforme Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Neurons in the frontal and temporal lobes of the brain are damaged in frontotemporal diseases (FTD), also known as frontotemporal dementia. As the patient population for FTD is growing, non-profit organisations, illness advocacy groups, and private organisations are currently concentrating on supporting treatment research. A major driver of the frontotemporal disorders treatment market growth is predicted to be the rising life expectancy rate, which is also expected to contribute to the increasing prevalence of neurological diseases among the older population. Apotex Inc., AstraZeneca plc., Auro Pharma, Johnson & Johnson, Mylan N.V., Pfizer Inc., Sanofi S.A., and Teva Pharmaceuticals USA, Inc. are just a few of the well-known worldwide and local businesses that are examined in the competitive landscape.